This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
October 22, 2023. Bipolar II Depression: Clinical Differentiation from MDD and an FDA-Approved Treatment.Presented at: Southern California Psychiatry Conference ; July 11-12, 2025; Huntington Beach, California. To BD or Not to Diagnose BD: That's the Question. Psychiatric Times. Accessed July 12, 2025.
AA Pharma; 2023. Commentary on the Canadian Network for Mood and Anxiety Treatments 2023 Clinical Guidelines for Management of Major Depressive Disorder in Adults - capturing the state of the art. On the Reality of Borderline PersonalityDisorder Fifty Years in Academic Psychiatry: A Conversation With Jesse H.
Persons JB. Cognitive-Behavioral Treatment of Borderline PersonalityDisorder. Springer; 2023:157-178. On the Reality of Borderline PersonalityDisorder Fifty Years in Academic Psychiatry: A Conversation With Jesse H. Guilford Press; 2015. The Case Formulation Approach to Cognitive-Behavior Therapy.
December 4, 2023. August 4, 2023. Neurosteroid Therapeutics “Offer Great Promise” in Postpartum Depression. Psychiatric Times. Accessed July 11, 2025. FDA Approves First Oral Treatment for Postpartum Depression in Adults. Psychiatric Times. Accessed July 11, 2025.
March 15, 2023. June 27, 2023. May 8, 2023. October 24, 2023. April 5, 2023. The White Lotus.” Season 3, episode 8. HBO; April 6, 2025. Gaslighting, narcissist, and more psychology terms you're misusing. Accessed April 10, 2025. When therapy goes wrong: the problem of underqualified psychotherapists.
BRIEF BOOK REVIEWS Popular Books Relevant to Mental Health The Best Minds: A Story of Friendship, Madness, and the Tragedy of Good Intentions Jonathan Rosen; Penguin Press, 2023 576 pages; $15 (hardcover) Reviewed by Edmund S. Laudor was a gifted young man: brilliant, charismatic and handsome.
In psychiatry, the DSM has provided a general definition of mental disorders since its third edition, guiding classification and diagnosis. Although the ICSD-3-TR is preferred by sleep clinicians and researchers over the DSM and ICD , it lacks a structured general definition.
August 2023. link] issues/2023/aug/power-pauses. Dr Sofair is a practicing psychiatrist and the author of The Beauty World Through The Lens of A Psychiatrist. References 1. 9 surprising ways you can benefit from a pause. Accessed July 14, 2025. Once an inspiration to Balanchine, Suzanne Farell now shows the way. May 5, 2025.
A 2023 study of surgery and urology residents showed that 52% of all residents experienced some form of mistreatment, with 88% of female respondents indicating negative experiences. 1 In addition, mistreated students are more likely to develop less empathy and more career regret.
May 10, 2023. 7 Although the mechanism of action of Rexulti is unknown, it has high receptor binding affinity to norepinephrine, serotonin, and dopamine receptors, and is an antagonist at norepinephrine α1B and α2C receptors and serotonin 5-HT2A receptors, as well as a partial agonist at serotonin 5-HT1A and dopamine D2 receptors.
In addition, ameliorating psychotropic drug-related weight gain and potential off-label benefits in other conditions commonly encountered in persons with mental disorders (eg, substance use disorder, alcohol use disorder, binge eating disorder) are also potential near-term clinical applications ( Table 3 ).
Facing stigma and discrimination, LGBTQ+ youth are over 4 times more likely to attempt suicide than their peers, and in 2023, 41% of LGBTQ+ youth reported seriously considering suicide. Robert Gebbia, the chief executive officers of the AFSP, stated 2 : “Eliminating this service will put young lives at risk.
Brexpiprazole (Rexulti; 2mg to 3mg per day) was approved in 2023 for this indication, he told attendees. May 11 , 2023. Fortunately, we have one agent that is on label now. for the treatment of patients with agitation associated with dementia due to Alzheimer’s,” Maguire explained. Press release. Accessed July 12, 2025.
Personal Statement : Dr. Young’s specific areas of clinical interest include treating complex mood disorders, anxiety and obsessive-compulsive disorders, personalitydisorders, and substance use disorders. I completed my residency at Johns Hopkins in 2023, where I served as a Chief Resident.
H ere we highlight the top ten of Mad in America’s most read blogs and personal stories of 2023. Mental Disorder Has Roots in Trauma and Inequality, Not Biology Allan M. Borderline PersonalityDisorder “No Longer Has a Place in Clinical Practice” Image depicts the thoughts and behaviors typically associated with BPD.
The same is true of attempts to reframe other diagnostic labels as ‘identities’—including the most contentious, ‘borderline personalitydisorder’ which, it is suggested, can be ‘destigmatised’ through ‘ neuroqueer feminism ’. Neuroqueer Feminism: Turning with Tenderness toward Borderline PersonalityDisorder. Johnson, M.
O n 3 August 2023, I wrote to the editors of two medical journals and called for retraction of three fraudulent reports of placebo-controlled trials of depression drugs in children and adolescents. Copenhagen: Institute for Scientific Freedom 2023;Nov 14. This is fraud. Arch Gen Psychiatry 2006;63:332-9. 17 Gøtzsche PC.
Related Videos Related Content Advertisement April 5th 2023 How A Psychoanalyst Brought His Field’s Thinking about Gender and Sexuality Into the 21st Century Jack Drescher, MD February 14th 2023 Sex, Loneliness, the Super Bowl, and Valentine’s Day H. Poster session presented at US Psych Congress Annual Meeting, Orlando, FL.
million Americans suffer from simultaneous mental health disorders and substance use disorders, clinically referred to as a dual diagnosis , highlighting the interconnected nature and urgency of these conditions [2]. link] Drug addiction (substance use disorder) – Diagnosis and treatment – Mayo Clinic. CBHSQ Data.
The Stichting Pill meticulously substantiated this in their response to the 2023 Multidisciplinary Document “Phasing Out Other Antidepressants. They kept attributing my symptoms to a non-objectifiable personalitydisorder which, according to the DSM, does not have to be permanent and which had been in remission for 10 years.
The National Centre for PTSD attributes this to the fact that men are more likely to experience trauma, but women are more likely to develop PTSD, possibly due to higher emotional sensitivity and reactivity, which increases susceptibility to mood disorders. There have also been notable shifts in the types of traumatic events leading to PTSD.
In 2023, Dryer resigned her medical license. Despite the seemingly common knowledge amongst core MDMA-AT researchers about sexual abuses in the 1980s, Torsten Passie’s 2023 Oxford University Press book The History of MDMA makes no mention of this. ” In Passie’s 2023 book, this concern has disappeared.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content